Navigation Links
US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
Date:2/28/2011

WASHINGTON, Feb. 28, 2011 /PRNewswire/ -- The U.S. Supreme Court today denied Novartis Pharmaceuticals Corporation's petition for certiorari, thereby refusing to disturb the liability judgment against Novartis issued by the Second Circuit in In re Novartis Wage & Hour Litigation, 611 F.3d 141 (2010). The Second Circuit held that thousands of U.S. sales representatives ("Reps") employed by Novartis are entitled to overtime pay because the Reps are not subject to either the "Outside Sales" or "Administrative" exemptions to overtime compensation under Federal, New York and California law.

In so ruling, the Second Circuit gave controlling deference to the opinion of the U.S. Secretary of Labor, who filed an amicus brief supporting the position that two exclusions to overtime pay – the Outside Sales and Administrative exemptions – did not apply to Novartis's Reps.

"The Court's denial of certiorari to Novartis is a victory for thousands of the company's Reps who labored long and hard for Novartis – often working over 70 hours a week – and yet were denied the overtime pay that is their due," said David Sanford, founding partner in Sanford Wittels & Heisler, LLP ("SWH"), the law firm representing the Novartis Reps.  "Everybody knows that justice delayed is justice denied.  We are hopeful that Novartis will do the right thing and carry out the Second Circuit's ruling by immediately instituting an overtime compensation system for its Reps and paying the Reps the overtime monies that the company has withheld for so many years."

Another SWH partner, Jeremy Heisler, pointed out that New York state recently amended its overtime laws and, effective April 11, 2011, an employer who fails to pay its employees required overtime compensation is subject to increased penalties.  "We are sure Novartis is aware of this development and will act accordingly to bring the Novartis overtime litigation to a just and expeditious resolution."

SWH serves as Lead or co-Lead Counsel for four new and nearly identical wage and hour class action suits now pending against other pharmaceutical companies by their U.S. sales representatives, including suits against Pfizer, Roche, Merck and Abbott Laboratories. SWH also recently secured the largest jury award in the U.S. in an employment discrimination case in May 2010 when a jury returned a verdict of $253 million in compensatory and punitive damage against Novartis Pharmaceuticals Corporation.  Novartis subsequently settled that case for $175 million.

About SWH

Sanford Wittels & Heisler LLP (SWH) is a law firm with offices in Washington, D.C., New York, and San Francisco that specializes in employment discrimination, wage and hour, consumer and complex corporate class action litigation and has represented thousands of individuals in some of the major class action cases in the United States. The firm also represents individual clients in employment, employment discrimination, sexual harassment, whistleblower, public accommodations, commercial, medical malpractice, and personal injury matters.


'/>"/>
SOURCE Sanford Wittels & Heisler LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Supreme Court of Israel Rules in Favor of Sun Pharma
2. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
3. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
6. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
7. Watson Announces Favorable District Court Ruling in Generic Mucinex® Patent Suit
8. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
9. Sensipar® Patents Upheld By District Court
10. U.S. District Court Rules from Bench in Lillys Favor, Confirms Validity of Alimta Patent
11. Occlutech Wins Dutch Appeal Court Ruling Against AGA Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):